Where the guideline stands	Insufficient evidence to recommend either way
Availability	Over the counter
How long before you judge it	Unclear
Pregnancy	Discuss with your clinician.
Sources behind this page	7, every one linked at the bottom

Resorcinol for Acne at a glance. Recommendation strength and evidence certainty are separate axes under GRADE.

What it is

Resorcinol is a simple phenol, benzene-1,3-diol, that has been applied to skin since the nineteenth century. It works as a keratolytic. A 2024 review in the Indian Journal of Postgraduate Dermatology describes it as disrupting keratin’s weak hydrogen bonds to produce a concentration-dependent desquamation, and credits it with some antibacterial and antifungal activity as well. The theory in acne is that shedding the plug of dead cells at the follicle opening should clear comedones. In the United States it appears only in over-the-counter acne products, at 2 percent as resorcinol or 3 percent as resorcinol monoacetate, and only alongside sulfur. The FDA’s acne monograph does not permit it as a standalone active ingredient.

What the evidence actually shows

The 2024 AAD guideline groups resorcinol with three other old ingredients in a single sentence: available evidence is insufficient to develop a recommendation on the use of topical glycolic acid, sulfur, sodium sulfacetamide and resorcinol for acne treatment.

The reason becomes obvious as soon as you go looking for trials. Resorcinol’s place in acne treatment was settled by regulation rather than by randomised comparison. The FDA’s current over-the-counter acne monograph, M006, lists “Resorcinol, 2 percent, when combined with sulfur” and “Resorcinol monoacetate, 3 percent, when combined with sulfur” among the permitted actives, alongside benzoyl peroxide, salicylic acid and sulfur. That status is inherited from a monograph process built around ingredients with long histories of marketed use. Being in the monograph means a product containing it can be sold without pre-market approval. It does not mean a trial showed it works.

When NICE assembled the trial evidence for its 2021 acne guideline, resorcinol appears nowhere in either of the two excluded-study appendices I checked, for mild-to-moderate and for moderate-to-severe acne. There was not even a poorly designed resorcinol trial to reject.

Secondary reviews are candid about this. Decker and Graber’s 2012 review of over-the-counter acne treatments in the Journal of Clinical and Aesthetic Dermatology notes that resorcinol has intrinsic antibacterial, antifungal and keratolytic activity, “however, it is not believed to be effective as monotherapy”, and that sulfur and resorcinol together cause mild irritation and sensitisation. That is the high-water mark of the case for it: a plausible mechanism, a long history of use, and no controlled acne data to put behind either.

How it is actually used

There is no good reason to seek it out. If you already own a product containing it, it will be a 2 percent resorcinol-with-sulfur cream, lotion or spot treatment applied once to three times a day to affected areas, and the sulfur is doing at least as much of the work as the resorcinol is. Keep it off large areas, off broken or ulcerated skin, and out from under occlusive dressings, and do not use it for long stretches; the reported harms cluster around repeated application to damaged skin. Salicylic acid sits in the same monograph and the same drugstore aisle, and unlike resorcinol it has an actual conditional recommendation from the AAD, made on low-certainty evidence. Benzoyl peroxide and topical retinoids are better supported still, and are the sensible default.

Safety and who should avoid it

Local irritation, dryness and contact sensitisation are the everyday problems. The rarer reports are what make resorcinol look like an ingredient whose time has passed. The 2024 Indian Journal of Postgraduate Dermatology review records that myxoedema and hypothyroidism have been reported, particularly after repeated application to ulcerated areas, and that red-cell effects including methaemoglobinaemia, haemolytic anaemia, haemoglobinuria and cyanosis have been documented in a few studies. Resorcinol is also listed among the agents implicated in exogenous ochronosis, the blue-grey discoloration usually associated with hydroquinone. These are case-report-level risks rather than expected effects at acne strengths, but they are the trade the ingredient asks of you in exchange for a benefit nobody has demonstrated. No acne-specific pregnancy data; ask a clinician.

Commonly repeated: Resorcinol is an FDA-recognised acne ingredient, so it must be proven to work. What the evidence actually shows: Appearing in the FDA’s over-the-counter acne monograph means a product containing it can be marketed without pre-market approval. It is an inherited regulatory permission, not a verdict on efficacy. The monograph does not even allow resorcinol on its own, only in combination with sulfur. The 2024 AAD guideline reviewed the acne evidence and found it insufficient to make any recommendation about resorcinol either way.

Sources

Keep reading

See where this sits against every other acne treatment on the acne treatment evidence map, or check how it combines with another ingredient in the ingredient combination checker. For the guideline’s own wording on this, see the 2024 AAD guideline, recommendation by recommendation.

Not medical advice

This page reports what the published evidence says about a treatment. It is not a treatment plan and it cannot account for your skin, your other medications or your medical history. Nothing here has been reviewed by a clinician; see our editorial policy for what that means. Talk to a clinician before starting or stopping any prescription treatment.

Research, not medical advice. Every clinical claim above links to the guideline, systematic review, trial or drug label it came from, so you can check it yourself rather than take my word for it. It was researched and drafted with AI assistance by a non-clinician, and no dermatologist has reviewed it: this site does the reading, it doesn’t practise medicine. It can’t account for your circumstances either, so talk to a dermatologist or doctor about your own skin, especially before starting or stopping a prescription treatment.

Resorcinol for Acne: An Old Ingredient, Thin Evidence